Utpal Pal Selected Research

Lyme Disease (Disease, Lyme)

2/2022	Correction: The Lyme disease agent co-opts adiponectin receptor-mediated signaling in its arthropod vector.
1/2022	Controlled Proteolysis of an Essential Virulence Determinant Dictates Infectivity of Lyme Disease Pathogens.
1/2022	Vaccines Against Vector-Borne Diseases.
11/2021	mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent.
11/2021	The Lyme disease agent co-opts adiponectin receptor-mediated signaling in its arthropod vector.
1/2021	A novel tick protein supports integrity of gut peritrophic matrix impacting existence of gut microbiome and Lyme disease pathogens.
10/2020	Protective Immunity and New Vaccines for Lyme Disease.
1/2020	A Novel Laminin-Binding Protein Mediates Microbial-Endothelial Cell Interactions and Facilitates Dissemination of Lyme Disease Pathogens.
1/2020	The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease.
11/2016	Lyme disease spirochaete Borrelia burgdorferi does not require thiamin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Utpal Pal Research Topics

Disease

30	Lyme Disease (Disease, Lyme) 02/2022 - 01/2004
29	Infections 01/2022 - 07/2002
4	Tick-Borne Diseases (Tick-Borne Disease) 01/2022 - 01/2016
3	Spirochaetales Infections 01/2018 - 01/2012
2	Tick Bites 11/2021 - 01/2017
2	Persistent Infection 01/2016 - 03/2009
2	Leptospirosis 01/2015 - 01/2013
2	Myocarditis (Carditis) 07/2014 - 11/2010
2	Bacterial Infections (Bacterial Infection) 07/2011 - 06/2009
1	Vector Borne Diseases 01/2022
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Virus Diseases (Viral Diseases) 11/2018
1	Joint Diseases (Joint Disease) 07/2014
1	Blister (Bulla) 05/2013
1	Inflammation (Inflammations) 03/2013
1	Arthritis (Polyarthritis) 08/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007
1	Dengue (Dengue Fever) 05/2007
1	Starvation 02/2007
1	Chronic Granulomatous Disease 07/2002

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
7	AntigensIBA 01/2022 - 01/2008
6	VaccinesIBA 01/2022 - 11/2010
5	AntibodiesIBA 01/2018 - 03/2009
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016 - 01/2008
3	LipidsIBA 11/2021 - 01/2017
3	Salivary Proteins and PeptidesIBA 11/2021 - 01/2009
3	CytokinesIBA 01/2016 - 10/2008
3	Lipoproteins (Lipoprotein)IBA 09/2015 - 03/2012
3	1-oleoyl-2-stearoylphosphatidylcholineIBA 03/2012 - 01/2004
2	Adiponectin ReceptorsIBA 02/2022 - 11/2021
2	Biological ProductsIBA 01/2021 - 10/2011
2	Peptides (Polypeptides)IBA 11/2018 - 03/2011
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2015
2	EpitopesIBA 01/2018 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2007
2	4,5-dibromo-2-pyrrolic acidIBA 07/2014 - 03/2012
2	Virulence Factors (Pathogenicity Factors)IBA 03/2013 - 03/2009
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2013 - 01/2012
2	Immunodominant EpitopesIBA 09/2011 - 03/2011
1	Recombinant ProteinsIBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	NucleosidesIBA 11/2021
1	SNARE Proteins (SNAREs)IBA 01/2021
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	PorinsIBA 01/2020
1	Laminin (Merosin)IBA 01/2020
1	Complement Factor H (Factor H)IBA 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 01/2020
1	AnionsIBA 11/2018
1	Artificial Membranes (Artificial Membrane)IBA 01/2018
1	DiglyceridesIBA 01/2017
1	AcidsIBA 01/2017
1	Thiamine (Aneurin)FDA Link 11/2016
1	diphosphoric acid (pyrophosphoric acid)IBA 11/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Peptide Elongation Factor Tu (EF-Tu)IBA 09/2015
1	Peptide Elongation Factors (Elongation Factor)IBA 09/2015
1	LipopolysaccharidesIBA 09/2015
1	16S Ribosomal RNAIBA 01/2015
1	Dermatan SulfateIBA 07/2014
1	DecorinIBA 07/2014
1	Peroxidase (Myeloperoxidase)IBA 05/2014
1	dityrosineIBA 05/2014
1	Dual OxidasesIBA 05/2014
1	chitobioseIBA 05/2013
1	chitin deacetylaseIBA 01/2013
1	Coenzyme A (CoA)IBA 11/2011
1	NAD (NADH)IBA 11/2011
1	Oxidoreductases (Dehydrogenase)IBA 11/2011
1	PeroxidesIBA 11/2011
1	Sulfhydryl Compounds (Thiols)IBA 11/2011
1	Peptide LibraryIBA 03/2011
1	Amino Acids FDA Link 11/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2008
1	p38 Mitogen-Activated Protein KinasesIBA 10/2008
1	Complement System Proteins (Complement)IBA 08/2008
1	rab GTP-Binding ProteinsIBA 05/2007
1	ClathrinIBA 05/2007
1	IronIBA 02/2007
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 07/2002
1	Nitroblue TetrazoliumIBA 07/2002
1	Superoxides (Superoxide)IBA 07/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 12/2007